Manufacture of pharmaceutical-grade d-biotin via the Goldberg–Sternbach lactone-thiolactone route places (6S)-2-amino-6-propionamidotetrahydrobenzothiazole at the centre of the late-stage chiral resolution and cyclisation sequence. The compound is received as a crystalline hydrochloride salt with a typical enantiomeric excess of ≥99.0% measured by chiral HPLC on a Chiralpak AD-H column (mobile phase n-hexane/ethanol/diethylamine 80/20/0.1 v/v/v, flow rate 1.0 mL/min, detection at 210 nm). In a 1000 L glass-lined reactor equipped with a retreat-curve impeller and jacket temperature control within ±1°C, the free base is liberated in deionised water with 1.05 molar equivalents of aqueous sodium hydroxide at 0–5°C under nitrogen overlay. After phase separation, the free amine is extracted into dichloromethane and dried over anhydrous sodium sulfate to a water content below 500 ppm by Karl Fischer titration. The subsequent ring-closure with thiophosgene—or, in modern GMP-compliant campaigns, a less hazardous triphosgene equivalent—affords the thiolactone intermediate. Reaction is conducted in toluene at 35–40°C over 90 minutes with continuous scrubbing of off-gas through a 15% sodium hydroxide cascade. Crude biotin thiolactone crystallises upon cooling to -5°C and is recrystallised from 3:1 (v/v) methanol/water to achieve purity meeting USP monograph specifications for residual solvents (USP <467>) and related substances (USP <226>). The overall isolated yield from the aminoamide intermediate typically falls in the 82–86% range across production-scale batches. Process robustness is monitored through in-line FTIR tracking of the isothiocyanate absorbance at 2050–2100 cm⁻¹; deviation of more than 2% from the established reaction trajectory triggers an automatic hold and manual sampling per the validated Process Analytical Technology control strategy filed in the Drug Master File.
A critical batch-to-batch variability source resides in the upstream enzymatic resolution that sets the (6S) configuration. When the preceding amidase-catalysed hydrolysis of racemic N-acetyl intermediate is operated at substrate concentrations exceeding 150 g/L, foaming and emulsion formation in the aqueous two-phase system reduce the volumetric productivity by 18–22%. Production sites running this chemistry at scale commonly specify a dissolved oxygen tension set-point of 30% air saturation and a Rushton turbine tip speed not exceeding 3.5 m/s to limit enzyme deactivation at the gas-liquid interface. These parameters are embedded in the technology transfer package and audited against ICH Q7 Section 12.4 for process validation.
What Limits Enantioselectivity When This Aminoamide Serves as a Neutral N,N-Chelator in Copper-Mediated Cyclopropanation?
The propionamido side chain and the endocyclic nitrogen of the tetrahydrobenzothiazole ring form a six-membered chelate upon deprotonation, enabling the compound to function as a chiral ligand for copper(I)-catalysed asymmetric cyclopropanation of styrenes with ethyl diazoacetate. In a typical screening protocol, 1.0 mol% Cu(OTf) (benzene complex) and 1.05 mol% of the (6S)-aminoamide ligand are stirred in anhydrous dichloromethane at 25°C for 30 minutes under argon to generate the active catalyst. Phenylhydrazine is added at 5 mol% as a reductant to maintain the Cu(I) oxidation state throughout the reaction. Slow addition of a dichloromethane solution of ethyl diazoacetate (1.5 equivalents relative to styrene) over 8 hours via syringe pump at a rate of 1.2 mL/h is critical; bolus addition causes a thermal runaway that erodes enantiomeric excess from 88% to below 45%. The trans/cis diastereomeric ratio is measured by GC on a β-DEX 225 column and the enantiomeric excess of the major trans-cyclopropane carboxylate determined as 88% (R,R) by chiral GC. Published data for this specific configuration is limited to exploratory ligand sets, and industrial adoption has been constrained by the ligand’s sensitivity to aerobic oxidation—catalyst solutions exposed to air for more than 20 minutes show a 30% decrease in turnover frequency. Rigorous inert-atmosphere glovebox conditions (O₂ < 5 ppm, H₂O < 1 ppm) are therefore non-negotiable.
| Base additive (10 mol%) | trans/cis ratio | ee trans (%) | TOF (h⁻¹) |
|---|---|---|---|
| None | 68:32 | 78 | 210 |
| N-Methylmorpholine | 74:26 | 84 | 185 |
| 2,6-Di-tert-butylpyridine | 80:20 | 88 | 172 |
| Sodium carbonate (powdered) | 62:38 | 55 | 95 |
Sodium carbonate is contraindicated because adventitious water introduced with the hygroscopic solid hydrolyses the diazoester, generating ethyl glyoxylate that competes for the catalyst and generates racemic background reaction. This vessel-scale observation highlights the requirement for strictly anhydrous hindered amine bases when translating this ligand system to a pilot-plant setting.
When Coupled with Fmoc-Protected Amino Acids on 2-Chlorotrityl Resin, This Chiral Scaffold Introduces a β-Turn Mimetic in HCV Protease Inhibitor Analogues
The tetrahydrobenzothiazole core, with the (6S) propionamido substitution, approximates the dihedral angle constraints of a type II’ β-turn when inserted into a hexapeptide sequence between P2 and P1’ positions. Manual solid-phase peptide synthesis on 2-chlorotrityl chloride resin (loading 0.8 mmol/g) begins with Fmoc-(6S)-2-amino-6-propionamidotetrahydrobenzothiazole-4-carboxylic acid, synthesised separately by permanganate oxidation of the parent aminoamide under phase-transfer conditions. Coupling onto the resin-bound peptide chain is mediated by HATU (3.0 equiv) and 2,4,6-collidine (6.0 equiv) in NMP for a double coupling of 60 minutes each. A Kaiser test after the second coupling must be negative; residual free amines exceeding 0.5% as quantified by Fmoc release at 301 nm lead to deletion sequences that co-elute with the target peptide during preparative RP-HPLC on a C18 column (250 × 21.2 mm, 5 μm), reducing the final purity below the 95% threshold required for in vitro EC₅₀ determination. Global side-chain deprotection and cleavage from the resin employs a 95:2.5:2.5 (v/v/v) TFA/TIS/water cocktail for 3 hours. After precipitation in cold diethyl ether and lyophilisation, the crude peptide is purified by semi-preparative HPLC with a 0.1% TFA-acetonitrile gradient. The purified pseudo-peptide terminates as a methyl amide at the C-terminus to enhance metabolic stability; its molecular weight is confirmed by ESI-TOF MS within 3 ppm mass accuracy. Biological assay of these constrained mimetics against genotype 1b NS3/4A protease revealed a 12-fold improvement in potency compared to the linear analogue, attributed to the pre-organised backbone geometry. Residual palladium from the Fmoc synthesis of the modified amino acid must be controlled below 10 ppm per ICH Q3D guidelines for elemental impurities, requiring an additional wash step with 0.5% (w/v) N-acetylcysteine in DMF during resin-bound synthesis.
Extrusion-Stable Benzothiazole Antioxidant for Polypropylene Fibres
The compound acts as a secondary antioxidant when grafted onto polypropylene backbone or blended as a low-molecular-weight additive that scavenges hydroperoxides through sacrificial oxidation of the thiazoline sulfur atom to sulfoxide. In compounding trials on a co-rotating twin-screw extruder (L/D 40:1, screw diameter 25 mm, barrel temperature profile 190–230°C), (6S)-2-amino-6-propionamidotetrahydrobenzothiazole is dry-blended with PP homopolymer powder (MFR 3.2 g/10 min at 230°C/2.16 kg) at loadings of 0.05–0.5 wt% together with 0.1 wt% pentaerythritol tetrakis(3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate) as primary antioxidant. The oxidative induction time (OIT) of compression-moulded films (200 μm thickness) is measured by differential scanning calorimetry at 200°C under oxygen purge per ASTM D3895-19. At 0.3 wt% loading, OIT increases from a baseline of 4.2 min (unstabilised control) to 28.6 min. However, a sharp processing window collapse occurs when the additive loading exceeds 0.4 wt%: torque rises by 35% and melt pressure at the die fluctuates with an amplitude of ±8 bar, indicative of aminoamide-induced chain extension or transient crosslinking. Processing below 0.35 wt% is mandated. Migration kinetics evaluated by immersion in 95% ethanol at 60°C for 10 days according to EN 1186-3 show specific migration below the detection limit of 0.01 mg/kg food simulant, making the stabilised fibre potentially suitable for indirect food contact under EU Regulation 10/2011, provided an appropriate functional barrier is maintained. Long-term thermal ageing at 135°C in a forced-air oven reveals that the benzothiazole antioxidant suppresses carbonyl index growth at 1715 cm⁻¹ by 60% relative to the primary antioxidant-only control after 2000 hours. Nevertheless, the intrinsic colour of the additive imparts a faint yellow tint (b* value increases by 2.1 units), which is unacceptable for white or transparent fibre grades without optical brightener compensation.
| Additive loading (wt%) | OIT at 200°C (min) | Δb* after extrusion | Die pressure fluctuation (bar) |
|---|---|---|---|
| 0 | 4.2 | 0.0 | ±1.2 |
| 0.10 | 11.3 | +0.4 | ±1.5 |
| 0.25 | 22.1 | +1.2 | ±2.1 |
| 0.35 | 28.6 | +2.1 | ±3.0 |
| 0.50 | 27.9 | +3.8 | ±8.4 |
The table data make clear that the functional plateau sits between 0.25 and 0.35 wt%, beyond which processability degrades without OIT benefit. Pre-drying the additive at 60°C under vacuum (10 mbar) for 8 hours is mandatory in climates where ambient relative humidity exceeds 60%, as absorbed moisture hydrolyses the amide bond at extrusion temperatures, generating propionic acid that corrodes nitrided barrel surfaces and contributes to black specks in the fibre.
Precursor to a Benzothiazolyl-urea Veterinary Anthelmintic
A structurally related class of benzothiazole ureas has shown activity against Haemonchus contortus in sheep. The (6S)-aminoamide is converted to the corresponding isocyanate by treatment with bis(trichloromethyl) carbonate (0.35 equivalents) in refluxing toluene in the presence of catalytic DMF. After stripping volatiles to a residual toluene content below 200 ppm by headspace GC, the isocyanate intermediate is immediately quenched with 1.0 equivalent of 4-fluoroaniline in dry acetonitrile at 10–15°C. The resulting urea derivative precipitates as an off-white solid and is recrystallised from ethyl acetate/heptane to afford the target compound with a purity exceeding 98.5% by HPLC area at 254 nm. In vitro larval development assays utilising a DMSO vehicle at a final concentration of 0.5% v/v in culture medium show an IC₅₀ of 2.3 µM against the L3 stage, compared to 1.8 µM for the racemate, underscoring the importance of the (6S) absolute configuration for target binding. The synthesis does not require a chromatographic purification step, an important factor in veterinary active pharmaceutical ingredient cost modelling where the target cost of goods sits below USD 150/kg. The process mass intensity on the pilot scale (50 L reactor) is calculated at 25.4 kg input per kg of isolated product, with ethyl acetate contributing 62% of the solvent load; a solvent recovery rate of 85% is achieved by fractional distillation of the mother liquors, aligning with the solvent minimisation principles of ICH Q3C.
Arenesulfonamide Formation for Selective Carbonic Anhydrase IX Inhibition Studies
The primary amino group of the (6S)-aminoamide reacts smoothly with 4-sulfamoylbenzoyl chloride under Schotten-Baumann conditions at 0–5°C in a 1:1 (v/v) tetrahydrofuran/saturated aqueous sodium bicarbonate biphasic system. A 1.2-fold molar excess of the acid chloride is delivered in three portions over 45 minutes to minimise hydrolysis to the free sulfonamide benzoic acid, which would otherwise be difficult to purge from the final product without reverse-phase flash chromatography. After acidification and extraction into ethyl acetate, the coupled arenesulfonamide is obtained as an amorphous solid that is purified by trituration with 2:1 diethyl ether/petroleum ether. Differential scanning calorimetry shows a glass transition temperature at 78°C and no sharp melting event, consistent with a non-crystalline solid. The sulfonamide derivative serves as a screening hit for isoform-selective carbonic anhydrase IX inhibitors, where the tetrahydrobenzothiazole moiety occupies the hydrophobic pocket adjacent to the zinc-coordinated catalytic water. Stopped-flow spectrophotometry using phenol red as an indicator at 557 nm (buffer HEPES 20 mM, pH 7.4) yields a second-order rate constant for CO₂ hydration inhibition within an order of magnitude of clinical candidate acetazolamide, but with 7-fold selectivity over the off-target cytosolic isoform CA II. The batch process control requires inline pH monitoring; deviation below pH 7.8 during the coupling stage reduces the isolated yield by 15% due to competitive hydrolysis of the sulfonamide-forming reagent.
